THC Therapeutics, Inc. (THCT)

THC Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Net Income	-0.81	-0.39	-1.52	-1.89	-1.93
Depreciation & Amortization	0	0	0.01	0.02	0.02
Other Amortization	-	-	0.01	0.28	0.43
Stock-Based Compensation	0.22	0.09	0.84	0.12	0.44
Other Operating Activities	0.13	-0.19	-0.33	0.57	0.03
Change in Inventory	-	0	0	-0	-
Change in Accounts Payable	0.28	0.36	0.6	0.42	0.29
Change in Other Net Operating Assets	0	0.04	-0.04	0.1	0.14
Operating Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59
Other Investing Activities	-	-	-	-0.15	-
Investing Cash Flow	-	-	-	-0.15	-
Short-Term Debt Issued	0.09	0.04	0.13	0.09	0.58
Total Debt Issued	0.09	0.04	0.13	0.09	0.58
Short-Term Debt Repaid	-0	-0.05	-0.05	-0.1	-0.27
Total Debt Repaid	-0	-0.05	-0.05	-0.1	-0.27
Net Debt Issued (Repaid)	0.09	-0.01	0.07	-0.01	0.31
Issuance of Common Stock	-	0.1	0.15	0.51	-
Repurchase of Common Stock	-	-	-0.1	-	-
Financing Cash Flow	0.18	0.09	0.12	0.79	0.31
Net Cash Flow	0	-0	-0.3	0.25	-0.27
Free Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04
Levered Free Cash Flow	0.2	0.03	-0.05	0.16	0.18
Unlevered Free Cash Flow	0.29	0.08	-0.01	0.22	0.06
Change in Working Capital	0.28	0.4	0.56	0.51	0.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.